Studies have demonstrated that disrupting peripheral dopaminergic nerves promotes tumour growth by triggering VEGF-dependent angiogenesis [53], whereas dopamine treatment reduces the migration of tumour-promoting endothelial progenitor cells from the bone marrow [61]. Here, VEGFA is linked to neoplasm.